Danaher Corporation Stock News

The U.S. continues to spend more money on healthcare than any other country. Healthcare spending totaled $4.3 trillion, according to the American Medical Association.

WASHINGTON , Nov. 21, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Evercore ISI HealthCONx Conf

In the shifting sands of the current stock market, discerning investors continue to navigate a labyrinth of uncertainties. Yet, the allure of long-term growth stocks remains undiminished.

For many years through 2022, it was becoming more difficult for active fund managers to make the case for their services, when broad index funds, with lower fees, were performing so well. But the tech

Regardless of whether you're a Wall Street veteran or new to investing, the past four years have been a roller coaster ride. A global pandemic brought a 14-year-long bull market to a screeching halt.

The stock market is on the downswing. Many traders are dumping their holdings as inflation, interest rates, and geopolitical crises weigh heavily on sentiment.

While Danaher (DHR) surpasses Q3 earnings and revenue estimates, the company's performance is hurt by a decrease in the sale of COVID-related products and weak demand in the Life Sciences segment.

Danaher (NYSE:DHR)'s third quarter earnings topped Wall Street estimates on the top and bottom lines but its weak guidance saw investors retreat from the stock.   The company - which designs, manufac

Everyone in the business media has a suggestion or two of what stocks Warren Buffett should buy or companies Berkshire Hathaway (NYSE: BRK-A , NYSE: BRK-B ) ought to acquire. I've written several arti

Danaher Corporation (NYSE:DHR ) Q3 2023 Earnings Conference Call October 24, 2023 8:00 AM ET Company Participants John Bedford - Vice President of Investor Relations Rainer Blair - President and Chief

Danaher (DHR) came out with quarterly earnings of $2.02 per share, beating the Zacks Consensus Estimate of $1.83 per share. This compares to earnings of $2.56 per share a year ago.

Danaher posts third-quarter earnings of $2.02 a share on revenue of $6.87 billion.

The trillion-dollar valuation club is not an easy one to reach. In fact, a grand total of just nine companies have reached this figure to-date.

Danaher's (DHR) Q3 results are likely to be hurt by weakness in the Biotechnology and Diagnostics segments due to a decrease in the sale of COVID-related products.

In an exclusive interview with Thomas Warner (TW) of Proactive London, Dr Jonathan Milner (JM), the founder of life sciences company Abcam PLC (NASDAQ:ABCM), discusses why he believes the $24 per shar